CMA Fights Pfizer, Flynn Appeal Of £63M Overcharging Fine
The U.K.'s competition watchdog hit back at drug giants Pfizer Ltd. and Flynn Pharma on Wednesday, saying the court should reject the companies' argument that £70 million ($86 million) in fines...To view the full article, register now.
Already a subscriber? Click here to view full article